| CAS ID: | 18323-44-9 |
| Molecular Formula: | C18H33ClN2O5S |
| Molecular Weight: | 425 g/mol |
| Monoisotopic Mass: | 424.1799 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | DALACIN C | U-21,251 | CHLORODEOXYLINCOMYCIN | CHLOROLINCOMYCIN | Cleocin | CLINDAMYCIN | CLEOCIN HYDROCHLORIDE | Cleocin T | Sobelin | Antirobe | CLEOCIN | CLINDAMYCIN HYDROCHLORIDE | U-25179E |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1 | See All |
| InChI Key: | KDLRVYVGXIQJDK-AWPVFWJPSA-N | |
| Smiles: | CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00636935 | Disease | Pulmonary fibrosis |
| Phase | Phase 4 | Status | Withdrawn |
| First Received | March 17, 2008 | Last Verified | June 27, 2017 |
| Sponsor | George Washington University | ||
| PubChem: | 446598 |
| ChEMBL: | CHEMBL1753 |